Tsutomu Mori has been in the pharmaceutical and biotech industry for more than 15 years. He started his career as a sales representative in Japan and has worked for Roussel, Wellcome, GlaxoWellcome and GlaxoSmithKline. About ten years ago, Tsutomu moved into business development and licensing and has since been involved in many licensing transactions in Japan.
Tsutomu moved to Melbourne, Australia in April 2004 and joined Biocomm Services. He was responsible for business development and licensing projects for biotech companies based in Australia, New Zealand, Japan, UK, Ireland, and the US.
At Biocomm2, Tsutomu is actively engaged with biotech and pharmaceutical companies for international licensing transactions, with a particular focus on the Japanese market.